500 mg Tablet

The Respiratory Quinolone

  • Superior choice in URTIs as well as LRTIs
  • Excellent bioavailability both orally (99%) and intravenously
  • The only fluoroquinolone approved by the U.S FDA for the treatment of Nosocomial Pneumonia
  • Good choice of antibiotic in persons with liver dysfunction 
  • Rapid onset of action to achieve quick response 
  • Convenient once-daily dosing

Download PDF